Similar articles

• Primary care and prescription drugs: coverage, cost-sharing, and financial protection in six European countries.

  Thomson S, Mossialos E. Thomson S, et al. Issue Brief (Commonw Fund). 2010 Mar;82:1-14. Issue Brief (Commonw Fund). 2010. PMID: 20411629
• Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures.

  Look KA, Arora P. Look KA, et al. Res Social Adm Pharm. 2016 Sep-Oct;12(5):682-98. doi: 10.1016/j.sapharm.2015.10.005. Epub 2015 Oct 28. Res Social Adm Pharm. 2016. PMID: 26632980
• Value-Based Pricing and State Reform of Prescription Drug Costs.

  Hwang TJ, Kesselheim AS, Sarpatwari A. Hwang TJ, et al. JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255. JAMA. 2017. PMID: 28692713 No abstract available.
• Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.

  Gaffney A, Lexchin J; US; Canadian Pharmaceutical Policy Reform Working Group. Gaffney A, et al. BMJ. 2018 May 17;361:k1039. doi: 10.1136/bmj.k1039. BMJ. 2018. PMID: 29773533 Review. No abstract available.
• The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

  Kesselheim AS, Avorn J, Sarpatwari A. Kesselheim AS, et al. JAMA. 2016 Aug 23-30;316(8):858-71. doi: 10.1001/jama.2016.11237. JAMA. 2016. PMID: 27552619 Review.